Transfusion Medicine Transformation at Vancouver Coastal ...

13
07/03/2016 1 1 Transfusion Medicine Transformation at Vancouver Coastal Health (VCH) Heather Mah, Regional Technical Practice Lead VCH Vancouver, Canada Immucor User Group 2016 Oakland California Effective Use of Automated Capture® Panels and ImmuLINK™ for Cross-Site Antibody Identification Province of British Columbia 357,000 sq miles ( California 163,700 sq miles) 4.5 million pop. Six Government funded Health Authorities administer health services Vancouver Coastal Health 2 Vancouver Coastal Health PRGH PHC SMH RH VGH LGH UBCH Whistler SGH Vancouver Coastal Health

Transcript of Transfusion Medicine Transformation at Vancouver Coastal ...

07/03/2016

1

1

Transfusion Medicine Transformation

at Vancouver Coastal Health (VCH)

Heather Mah, Regional Technical Practice Lead VCH Vancouver, Canada

Immucor User Group 2016 Oakland California

Effective Use of Automated Capture® Panels and ImmuLINK™

for Cross-Site Antibody Identification

Province of British Columbia

• 357,000 sq miles

( California 163,700 sq miles)

• 4.5 million pop.

• Six Government funded Health Authorities administer health services

Vancouver Coastal Health

2

Vancouver Coastal Health

PRGH

PHC

SMH

RH

VGH

LGH

UBCH

Whistler

SGH

Vancouver Coastal Health

07/03/2016

2

Service Delivery Model

4

Vancouver General Hospital

VGH serves as a hub site for 10 facilities

Lions Gate Hospital

• Average travel time from LGH for urgent

antibody investigation samples is 67

minutes via the Lions Gate Bridge

Richmond Hospital

46,000 T/S annually 7,000 T/S annually

7,000 T/S annually

• More effective automation for large hub site

• Lean workflow

• Scalable automation appropriate for community hospitals

• Centralized data management

• Efficient cross-site antibody identification

VCH TM Transformation Goals 2013/14

5

Better Automation at VGH

6

• Expanded test menu including testing of AI panels (T/S, ABR1, XM, panels, donor

unit confirm,)

• Large through-put

• Continuous access to load and unload samples and reagents at any time

• Dynamic scheduling - run tests in any order

07/03/2016

3

LEAN Principles Application VGH

7

Original State

LEAN Principles Application VGH

LEAN = Eliminating waste, cycle time reduction for STAT Group and Screen Testing

• Create a value-stream map of the original state

• Develop new workflow to reduce non-value added time

• Redesign bench configuration and analyzers’ placement

• Move NEO®s to new location /Add Echo®

• Measure various parameters to assess benefits.

8

LEAN Principles Application VGH

9

ECHO

07/03/2016

4

LEAN Principles Application VGH

10

LEAN Principles Application VGH Parameter Original State Renewed State

Total travel distance

433 sq ft 145 sq ft

Employee travel time to check results

1.25 hrs/day 0 hrs/day

TAT for T/S from ER

1 hr 10 min (average for first 8 months)

1 hr 5 min (average since repositioning of NEOs)

11

TAT increased at implementation

Scalable Automation

12

ECHO® • Efficiency gains at LGH

and RH

• Improved standardization of test set up and reading

• Opportunity to shift some Antibody Identification testing closer to patient

07/03/2016

5

Centralized Data Management

13

ImmuLINK™

ImmuLINK™

• ImmuLINK™ middleware allows web-based review of data from multiple instruments

Centralized Data Management

14

ImmuLink

serverSunquest

VNEO1

VNEO2

LECHO1

RECHO

VIMLNK

LIMLNK

RIMLNK

NEO® and Echo®

(Immucor) Analyzers

ImmuLINK™ Implementation Process

15

VCH MULTI-SITE TMS ANALYZER IMPLEMENTATION TIMELINEDates: May 1, 2013 to July 31, 2014

List of Activities Days Jul/13 Jan/14 Jul/14

Implementation Processes at VCH

NEO/ECHO Installation and Validation - VGH/LGH 98

ImmuLINK Installation and Setup 49

Sunquest Software Development 63

ImmuLINK and Sunquest Configuration/Testing 49

Document Creation - Operating Procedures 161

Document Creation - Test Scripts 56

NEO and ImmuLINK Training - VGH 56

ECHO and ImmuLINK Training - LGH 119

ImmuLINK Virtualization at KDC 49

Security and Privacy Review Process 133

KDC ImmuLINK Server Installation and Validation 66

ECHO Installation and Validation - RH 28

ECHO and ImmuLINK Training - RH 64

* VGH - Vancouver General Hospital LGH - Lions' Gate Hospital RH - Richmond HospitalRH - Richmond Hospital

VGH/LGH Analyzers & ImmuLINK LIVE

18-Nov-2013

ImmuLINK @ KDC LIVE20-Mar-2014

2

3

4

1

RH ECHO LIVE15-Jul-2014

07/03/2016

6

ImmuLINK™ Implementation Challenges

16

• ImmuLINK Virtualization – Kamloops Data Center (KDC)

• Lack of redundancy, backup, and support on ImmuLINK server hardware – Initiate plans to virtualize the server to KDC

• Application to HSSBC privacy office for review to fulfill security and privacy concerns

• Re-validation of ImmuLINK™ at KDC

4

17

Effective Use of Automated Capture® Panels and ImmuLINK™

for Cross-Site Antibody Identification

Reagent Panels • Pre-dispensed

• Stable for 120 days from manufacture

• 3 different solid phase panels

• Easy to use on automated platform (automated panels)

• Assay TAT = 27 minutes on Echo

• 69% of investigations can be completed using only these panels

Efficient Antibody Identification

18

07/03/2016

7

Automated Panels for AI

19

• Antibody investigations – Can be performed using

only automated panels 69% of the time (N=489)

• ImmuLINK™ middleware allows web-based review of data from multiple instruments

ImmuLINK™

20

ImmuLink

serverSunquest

VNEO1

VNEO2

LECHO1

RECHO

VIMLNK

LIMLNK

RIMLNK

NEO® and Echo®

(Immucor) Analyzers

ImmuLINK™ - Multiple Sites

21

Test site LGH - panel results viewed at VGH

01:35

02:12

07/03/2016

8

ImmuLINK™ - Multiple Sites

22

Report from ImmuLINK™

- Test site LGH (02:12)

- Retrieved & interpreted at

VGH (02:30)

ImmuLINK™ - Multiple Sites

23

Report from ImmuLINK™

- Anti-Fya interpretation at VGH (3:20 AM phone report to LGH)

Sample arrives

at VGH 02:45

LEAN Principles Application VCH

LEAN = Eliminating waste, cycle time reduction for STAT Group and Screen Testing

• Create a value-stream map of the original state

• Develop new workflow to reduce non-value added time and incorporate technology enhancement

• Implement new workflow at LGH and VGH

• Measure TAT for urgent antibody investigations for 10 weeks to assess the benefit.

24

07/03/2016

9

Cross-Site AI: Original State

Complete Forms

Notify VGH

Package & and

Send out Sample

First Antibody ID Panel by Manual GEL

Secondary Panels

Pheno- typing

Report to LGH

25

Start

1 hour

2 hours

3 hours

4 hours

5 hours

Travel time = Waste

Mean TAT for urgent cross-

site antibody investigations

was 4.6 hours. Target TAT is

4 hours.

LGH Activities VGH Activities

New Positive

Antibody Screen

Cross-Site AI: Improved TAT

First Antibody ID

Panel

Notify VGH

Package & and

Send out Sample

First Panel Secondary

Panels - typing

Report to LGH

26

Start

1 hour

2 hours

3 hours

4 hours

5 hours

LGH Activities

VGH Activities

New Positive

Antibody Screen

First Panel

Print Immu-LINK

report

First Panel

Exclu-sions

Secondary Panels

Pheno- typing

Report to LGH ImmuLINK™ Report

Change in mean TAT to 3.3 hours from 4.6

hours for original state

07/03/2016

10

• 34 urgent antibody investigations with cross-site collaboration

• Specificity assigned in 59% of cases as indicated in table

Measure cont’d

28

SPSA = pan-reactive, negative DAT, negative PEG

Unidentified = exclusions complete, unexplained

reactions in solid phase and/or PEG

• 38% of the cases had nonspecific reactions (mean TAT for this group 3.1 hours)

• Immucor acknowledged higher rates of equivocal and unexpected results with Capture™ reagents

• Potential impact on patient care and additional resources

• Negates some of the benefits of panels and ImmuLINK™ for cross-site AI.

Measure cont’d

29

SPSA = pan-reactive, negative DAT, negative PEG

Unidentified = exclusions complete, unexplained

reactions in solid phase and/or PEG

Conclusions

30

Benefit of new workflow and technology was a change in mean TAT to 3.3 hours from 4.6 hours for original state

1st panel results available to VGH via ImmuLINK™ shortly after referral by LGH and before arrival of sample

Opportunities to further decrease TAT by testing with additional Ready-ID® panels at referring sites

07/03/2016

11

Conclusions

31

LGH staff is pleased to have more

involvement in the AI process and

have ability to perform preliminary

analysis of the first panel

VGH staff noted a reduction in

hands-on time and TAT to complete

the investigations

32

NEW Positive Antibody

Screen requiring STAT

AI Process

Run Ready-ID on ECHO STAT

Order VAI* Test in

Sunquest

Complete Referral AI

Request Form

Ensure timing of Panel

Completion is recorded

Fax & Phone request for STAT AI to

VGH

Order Additional Samples if

needed

Package Samples for

Sendout

Send out samples via

CAB or COURIER

Print Panel & Screen Report

from ImmuLINK

Perform Exclusions and

Initial Conclusion

If Additional Solid Phase Panels are...

Arrived

NOT Arrived

Contact RH / LGH

to perform panel testing

Receive Call and run

requested panel onto ECHO STAT

Phone VGH when testing

complete

Samples arrive at VGH

PhoneRH / LGH with Final

Results

RH / LGH to order

Phenotyped Units if

required

Crossmatch Units,

Phenotyping as required

Fax & Phone received from

RH / LGH, note time of

Panel Completion

RH

/ L

GH

Pro

cess

VG

H P

roce

ss

Complete AI Process

Not RequiredWait for

Samples to arrive

Required and if Samples

have...

SAMPLES

If Patient still at RH / LGH...

* RH use STAT priority LGH use Urgent priority

Referral Antibody Investigation Flow

• More effective automation for VGH √

• LEAN workflow √

• Scalable automation appropriate for LGH & RH √

• Centralized data management - ImmuLINK™ √

• Efficient cross-site antibody identification √

Transformation Goals Accomplished

33

07/03/2016

12

Issue: • Files with multiple Master

Lists (ML) • Each of the 3 sites may

have different Capture-R® Ready-ID® panels in use

• Potential for error when selecting (ML) on which to transcribe results from ImmuLINK™ report

• Time consuming to transcribe results

Working Collaboratively with Immucor

34

Proposed ImmuLINK™ enhancements:

1. Panel Identification

• System selects lot number of panel

• ImmuLINK report results print on Master List

2. Algorithm for rule outs

3. Manual panels

• Save and store in data base

• Useful for select cells

Working Collaboratively with Immucor

35

Acknowledgements

36

Executive Sponsor Richard Walker

Medical Leads Dr. Kate Chipperfield, Dr. Kristine Roland

Technical Supervisor (VGH) Pam Danesin

Project Managers Ellie Sheng (LIS) Heather Mah (Lab)

LIS Steve Arai

Technical Support/Trainer Luca Rizzetto

Technical Support/ImmuLINK Lawrence Sham

LEAN Project Margaret Walsh

K/O – Trainers, Site Champion Pam Danesin, Kate Chan, Shelley Tapp (LGH) Teresa Sharp (RH)

Learning and Ideas All staff!

07/03/2016

13

Thank you

37

Questions?